Level 1 ATC classes by share of public drug plan costs Canada 2020/2021

In fiscal year 2020/2021, the nervous system was the third ranked level 1 ATC therapeutic class by share of total drug costs with nearly 11 percent. This statistic depicts the top 10 level 1 ATC therapeutic classes by share of total drug costs in FY 2020/2021. ATC stands for the Anatomical Therapeutic Chemical (ATC) classification system as it is maintained by the World Health Organization.

Leading level 1 ATC therapeutic classes by share of total drug costs in select Canadian public drug plans in 2020/2021

Characteristic	Share of total drug costs
Antineoplastic and immunomodulating agents	29.5%
Alimentary tract and metabolism	14.4%
Nervous system	10.8%
Antiinfectives for systemetic use	7.3%
Cardiovascular system	6.7%
Sensory organs	6.3%
Respiratory system	5.9%
Blood and blood forming organs	5.8%
Musculo-skeletal system	2.9%
Genito-urinary system and sex hormones	2%

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

Release date

2023

More information

Region

Canada

Survey time period

fiscal year 2020/2021

Supplementary notes

The therapeutic classes reported are the level 1 category of the World Health Organization’s Anatomical Therapeutic and Chemical (ATC) classification system. The public drug plans include British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland and Labrador, Yukon, and the Non-Insured Health Benefits Program.

Citation formats